Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-24-194852
Filing Date
2024-08-06
Accepted
2024-08-06 16:01:36
Documents
18
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A d795753d10qa.htm   iXBRL 10-Q/A 48702
2 EX-31.1 d795753dex311.htm EX-31.1 4276
3 EX-31.2 d795753dex312.htm EX-31.2 4365
  Complete submission text file 0001193125-24-194852.txt   354155

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA idya-20240331.xsd EX-101.SCH 5695
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE idya-20240331_cal.xml EX-101.CAL 962
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE idya-20240331_def.xml EX-101.DEF 15193
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE idya-20240331_lab.xml EX-101.LAB 20111
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idya-20240331_pre.xml EX-101.PRE 16033
20 EXTRACTED XBRL INSTANCE DOCUMENT d795753d10qa_htm.xml XML 17812
Mailing Address 7000 SHORELINE CT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE CT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

EIN.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-38915 | Film No.: 241178980
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)